Beat Joint Pain The Options Library
Educational information only. No diagnosis, treatment recommendation, personalized dose, or emergency service.

HomePrescriptionJAK inhibitors

Independent source profile

JAK inhibitors

Janus kinase inhibitors are targeted prescription medicines used for certain inflammatory conditions. Their place in treatment, approved uses, and warnings are product-specific and require professional evaluation.

ClassificationPrescription targeted DMARD class
PurposeDisease-modifying therapy for selected diagnosed inflammatory conditions
Last source checkAugust 3, 2026
Editorial statusIndependent • Not sponsored

Product identity

What it is

Active ingredient or category: Examples include tofacitinib and other product-specific agents

Regulatory classification: Prescription targeted DMARD class

What official sources say

  • The MedlinePlus page for tofacitinib includes prominent infection, cancer, cardiovascular, and clot-related warnings.
  • A class name does not replace the prescribing information for the exact product.
Safety signal—not a complete warning list: These medicines carry serious risks and are not appropriate for self-selection. Review the current FDA-approved labeling and medication guide with the prescribing team. Always read the current label or source for the exact product.

Questions to take to a clinician or pharmacist

  1. Why is this product being considered for my diagnosed condition?
  2. Which boxed warnings and personal risk factors should we discuss?
  3. What monitoring, vaccines, and infection precautions apply?

Sources reviewed

Links open the authoritative source. Product labels and guidance can change; verify the current version before relying on any summary.

Review status: This page received an editorial source check on August 3, 2026. No clinician or pharmacist is credited as independently reviewing it. Report a correction.

More in Prescription

Prescription

Prescription NSAIDs

Prescription nonsteroidal anti-inflammatory drugs are used in several joint-related conditions to address pain and inflammation. They do not all have the same dosing, interactions, or risk profile, and they are not disease-modifying therapy for inflammatory arthritis.

Read source profile
Prescription

Methotrexate

Methotrexate is a prescription disease-modifying antirheumatic drug used for diagnosed conditions such as rheumatoid arthritis and certain other inflammatory diseases. It is not a general pain medicine for unexplained joint pain.

Read source profile
Prescription

TNF inhibitors

Tumor necrosis factor inhibitors are biologic medicines used in selected diagnosed inflammatory diseases. They are not stronger versions of an ordinary pain reliever and are prescribed within a condition-specific plan.

Read source profile